INTRODUCTION: Population health is one of the highest priorities for countries, which can translate into increased economic prosperity. This encourages research on health in an economic context. METHODS: The objective was to assess the relationships between health spending, treatable respiratory mortality, and gross domestic product (GDP) in countries of the Organization for Economic Co-operation and Development (OECD). The research was conducted with respect to health systems (tax-based, insurance-based) and gender differentiation of the productive population (aged 25-64 years). Descriptive analysis, regression analysis, and cluster analysis were used to achieve the main objective. The data covered the period from 1994 to 2016. RESULTS: The results of the regression analysis revealed negative relationships between health spending and treatable respiratory mortality in countries with a tax-based health system for male and female working-age populations, as well as in countries with an insurance-based health system for male population. This means that higher health spending was associated with lower treatable respiratory mortality. Also, lower treatable mortality was associated with higher GDP, especially in the male productive population from countries with an insurance-based health system. In this study, countries with a tax-based health system were characterized by higher health spending, lower rates of treatable mortality from respiratory system diseases, and higher GDP compared to countries with an insurance-based health system. Males reported a higher mortality rate than females. Among the countries with a tax-based health system, the United Kingdom and Latvia showed less positive outcomes, while Italy and Iceland were the countries with the most positive outcomes. Among the countries with an insurance-based health system, Hungary and Slovakia reported poor outcomes, while France, Switzerland and Luxembourg were characterized by very positive outcomes. The United States showed a high mortality rate despite its high economic outcomes, i.e., health spending and GDP. DISCUSSION: Health care financing in particular is one of the instruments of health policy. It seems that the leaders of countries should ensure a sufficient level of health financing, as higher health spending can contribute to lower mortality rates in a country. This may translate into higher productivity. Especially countries with underfunded health systems should increase their health spending.

Center for Applied Economic Research Faculty of Management and Economics Tomas Bata University in Zlín Zlín Czechia

Institute of Earth Resources Faculty of Mining Ecology Process Control and Geotechnologies Technical University of Košice Košice Slovakia

Zobrazit více v PubMed

European Commission . Commission Staff Working Document—Investing in Health. (2013). Available online at: https://ec.europa.eu/health/sites/health/files/policies/docs/swd_investing_in_health.pdf (accessed November 18, 2021).

Mihalache IC. Health state of human capital in the economic theory. Postmodern Open. (2019) 10:182–92. 10.18662/po/102 DOI

Sharma R. Health and economic growth: evidence from dynamic panel data of 143 years. PLoS ONE. (2018) 13:e0204940. 10.1371/journal.pone.0204940 PubMed DOI PMC

Cylus J, Permanand G, Smith PC. Making the economic case for investing in health systems. What is the evidence that health systems advance economic and fiscal objectives?, In: Kluge H, Figueras J, eds Health Systems for Prosperity and Solidarity. Copenhagen: European Observatory Policy Brief Series. (2018).

Papanicolas I, Smith PC. Health System Performance Comparison. An Agenda for Policy, Information and Research. Berkshire, England: Open University Press; (2013). p. 390. Available online at: https://www.euro.who.int/__data/assets/pdf_file/0009/244836/Health-System-Performance-Comparison.pdf (accessed November 18, 2021).

Gay JG, Paris V, Devaux M, De Looper M. Mortality Amenable to Health Care in 31 OECD Countries. Estimates and Methodological Issues OECD Health Working Papers No 55. Paris: OECD Publishing; (2011).

Feller A, Schmidlin K, Clough-Gorr KM. Trends and socioeconomic inequalities in amenable mortality in Switzerland with international comparisons. Swiss Med Wkly. (2017) 147:w14478. 10.4414/smw.2017.14478 PubMed DOI

Nolasco A, Quesada JA, Moncho J, Melchor I, Pereyra-Zamora P, Tamayo-Fonseca N, et al. Trends in socioeconomic inequalities in amenable mortality in urban areas of Spanish cities, 1996–2007. BMC Public Health. (2014) 14:299. 10.1186/1471-2458-14-299 PubMed DOI PMC

OECD/Eurostat . Avoidable Mortality: OECD/Eurostat Lists of Preventable and Treatable Causes of Death (November 2019 version). (2019). Available online at: https://www.oecd.org/health/health-systems/Avoidable-mortality-2019-Joint-OECD-Eurostat-List-preventable-treatable-causes-of-death.pdf (accessed November 18, 2021).

Weber A, Clerc M. Deaths amenable to health care: converging trends in the EU? Health Policy. (2017) 121:644–52. 10.1016/j.healthpol.2017.03.017 PubMed DOI

Nolte E, McKee M. Variations in amenable mortality-trends in 16 high-income nations. Health Policy. (2011) 103:47–52. 10.1016/j.healthpol.2011.08.002 PubMed DOI

Gianino MM, Lenzi J, Bonaudo M, Fantini MP, Siliquini R, Ricciardi W, et al. Patterns of amenable child mortality over time in 34 member countries of the Organisation for Economic Co-operation and Development (OECD): Evidence from a 15-year time trend analysis (2001–2015). BMJ Open. (2019) 9:e027909. 10.1136/bmjopen-2018-027909 PubMed DOI PMC

Lumme S, Manderbacka K, Karvonen S, Keskimäki I. Trends of socioeconomic equality in mortality amenable to healthcare and health policy in 1992–2013 in Finland: a population-based register study. BMJ Open. (2018) 12:e023680. 10.1136/bmjopen-2018-023680 PubMed DOI PMC

McCallum AK, Manderbacka K, Arffman M, Leyland AH, Keskimäki I. Socioeconomic differences in mortality amenable to health care among Finnish adults 1992–2003: 12 year follow up using individual level linked population register data. BMC Health Serv Res. (2013) 13:3. 10.1186/1472-6963-13-3 PubMed DOI PMC

Mullachery PH, Rodriguez DA, Miranda JJ, López-Olmedo N, Martinez-Folgar K, Barreto ML, et al. Mortality amenable to healthcare in Latin American cities: a cross-sectional study examining between-country variation in amenable mortality and the role of urban metrics. Int J Epidemiol. (2022) 51:303–13. 10.1093/ije/dyab137 PubMed DOI PMC

Nolte E, McKee CM. In amenable mortality–deaths avoidable through health care–progress in the US lags that of three European countries. Health Aff. (2012) 31:2114–22. 10.1377/hlthaff.2011.0851 PubMed DOI

Gianino MM, Lenzi J, Fantini MP, Ricciardi W, Damiani G. Declining amenable mortality: a reflection of health care systems? BMC Health Serv Res. (2017) 17:735. 10.1186/s12913-017-2708-z PubMed DOI PMC

Gianino MM, Lenzi J, Muça A, Fantini MP, Siliquini R, Ricciardi W, et al. Declining amenable mortality: time trend (2000–2013) and geographic area analysis. Health Serv Res. (2017) 52:1908–27. 10.1111/1475-6773.12563 PubMed DOI PMC

Hone T, Rasella D, Barreto M, Atun R, Majeed A, Millett C. Large reductions in amenable mortality associated with Brazil's primary care expansion and strong health governance. Health Aff. (2017) 36:149–58. 10.1377/hlthaff.2016.0966 PubMed DOI

Neethling I, Groenewald P, Schneider H, Bradshaw D. Trends and inequities in amenable mortality between 1997 and 2012 in South Africa. S Afr Med J. (2019) 109:597–604. 10.7196/SAMJ.2019.v109i8.13796 PubMed DOI

Jarčuška P, Janičko M, Barták M, Gavurová B, Vagašová T. Mortality amenable to health care in European Union countries and its limitations. Cent Eur J Public Health. (2017) 25:S16–22. 10.21101/cejph.a4956 PubMed DOI

McMinn MA, Seaman R, Dundas R, Pell JP, Leyland AH. Socio-economic inequalities in rates of amenable mortality in Scotland: analyses of the fundamental causes using the Scottish longitudinal study, 1991–2010. Popul Space Place. (2020) 28:e2385. 10.1002/psp.2385 PubMed DOI PMC

Mesceriakova-Veliuliene O, Kalediene R, Sauliune S, Urbonas G. Amenable mortality inequalities and their changes by place of residence during 1990–2019: the case of Lithuania. Public Health. (2021) 200:99–105. 10.1016/j.puhe.2021.09.022 PubMed DOI

Sundmacher L. Trends and levels of avoidable mortality among districts: “healthy” benchmarking in Germany. Health Policy. (2013) 109:281–9. 10.1016/j.healthpol.2012.07.003 PubMed DOI

Westerling R. Decreasing gender differences in “avoidable” mortality in Sweden. Scand J Public Health. (2003) 31:342–9. 10.1177/14034948030310050201 PubMed DOI

Lefèvre H, Jougla E, Pavillon G, Le Toullec A. Disparités de mortalité “prématurée” selon le sexe et causes de décès “évitables” [Gender differences in premature mortality and avoidable deaths]. Rev Epidemiol Sante Publique. (2004) 52:317–31. 10.1016/S0398-7620(04)99061-X PubMed DOI

de Abreu DM, César CC, França EB. Diferenciais entre homens e mulheres na mortalidade evitável no Brasil (1983–2005) [Gender differences in avoidable mortality in Brazil (1983-2005)]. Cad Saude Publica. (2009) 25:2672–82. 10.1590/S0102-311X2009001200014 PubMed DOI

Murphy KM, Topel RH. The value of health and longevity. J Polit Econ. (2006) 114:871–904. 10.1086/508033 DOI

Husain MJ. Contribution of health to economic development: a survey and overview. Econ. (2010) 4:1–52. 10.5018/economics-ejournal.ja.2010-14 DOI

Verstraeten SPA, van Oers HAM, Mackenbach JP. Contribution of amenable mortality to life expectancy differences between the Dutch Caribbean islands of Aruba and Curaçao and the Netherlands. Rev Panam Salud Publica. (2020) 44:e38. 10.26633/RPSP.2020.38 PubMed DOI PMC

Rotar LJ, Pamić RK, Bojnec Š. Contributions of small and medium enterprises to employment in the European Union countries. Econ Res. (2019) 32:3302–14. 10.1080/1331677X.2019.1658532 DOI

Bojnec Š, Marčeta M. Analysis of the economic performance and competitiveness of European Union countries. Serbian J Manag. (2022) 17:219–36. 10.5937/sjm17-31944 DOI

Alkire BC, Peters AW, Shrime MG, Meara JG. The economic consequences of mortality amenable to high-quality health care in low- and middle-income countries. Health Aff. (2018) 37:988–96. 10.1377/hlthaff.2017.1233 PubMed DOI

Herzer D, Nagel K. The impact of adult and non-adult mortality on development: Two centuries evidence from a panel of industrial countries. J Policy Model. (2019) 4:352–71. 10.1016/j.jpolmod.2019.02.008 DOI

Kozlova OA, Nifantova RV, Makarova MN. Methods of the assessment of economic losses caused by the mortality of the population employed in regional economy. Econ Reg. (2017) 13:511–23. 10.17059/2017-2-16 DOI

Heijink R, Koolman X, Westert GP. Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries. Eur J Health Econ. (2013) 14:527–38. 10.1007/s10198-012-0398-3 PubMed DOI

Currie J, Guzman Castillo M, Adekanmbi V, Barr B, O'Flaherty M. Evaluating effects of recent changes in NHS resource allocation policy on inequalities in amenable mortality in England, 2007–2014: time-series analysis. J Epidemiol Commun Health. (2019) 73:162–7. 10.1136/jech-2018-211141 PubMed DOI PMC

Eurostat . Respiratory Diseases Statistics. Available online at: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Respiratory_diseases_%20statistics&oldid=497079#Deaths_from_diseases_of_the_respiratory_system (accessed November 18, 2021).

Martinez R, Lloyd-Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study. Lancet Glob Health. (2020) 8:e511–23. 10.1016/S2214-109X(20)30035-8 PubMed DOI

Agedew E, Boda B, Kanko T, Estifanos W, Shibiru T. Chronic obstructive pulmonary disease and associated factors in Arba Minch Health and Demographic Surveillance Site, 2020. Int J Chron Obstruct Pulmon Dis. (2021) 16:2953–2962. 10.2147/COPD.S319721 PubMed DOI PMC

GBD 2015 Chronic Respiratory Disease Collaborators . Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. (2017) 5:691–706. 10.1016/S2213-2600(17)30293-X PubMed DOI PMC

European Respiratory Society . Forum of international respiratory societies. The global impact of respiratory disease–second edition. Available online at: https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf (accessed November 18, 2021).

D'Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, et al., Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med. (2021) 13:eabj7790. 10.1126/scitranslmed.abj7790 PubMed DOI PMC

OECD . Health Spending. Available online at: https://data.oecd.org/healthres/health-spending.htm#indicator-chart (accessed November 18, 2021).

OECD . Gross Domestic Product (GDP). Available online at: https://data.oecd.org/gdp/gross-domestic-product-gdp.htm (accessed November 18, 2021).

WHO . WHO Mortality Database. Available online at: https://www.who.int/data/data-collection-tools/who-mortality-database?fbclid=IwAR2gVBBqbMEUf6Y1g505FjN_hg77TkINf_VWGO3-efYrTr-J9sC7_Wkpy7Q (accessed November 18, 2021).

United Nations . World Urbanization Prospects 2018. Available online at: https://population.un.org/wup/ (accessed November 18, 2021).

Paris V, Devaux M, Wei L. Health Systems Institutional Characteristics: A Survey of 29 OECD Countries. OECD Health Working Papers, No 50 Paris: OECD Publishing. (2010).

OECD . Health Systems Characteristics Survey. (2016). Available online at: https://qdd.oecd.org/subject.aspx?Subject=hsc (accessed November 18, 2021).

European Commission . Country Health Profiles 2017. Available online at: https://ec.europa.eu/health/state/country_profiles/2017_en (accessed November 18, 2021).

OECD . Country Health Profiles. (2019). Available online at: http://www.oecd.org/health/health-systems/country-health-profiles-EU.htm (accessed November 18, 2021).

Kassambara A. Practical Guide to Cluster Analysis in R: Unsupervised Machine Learning (Volume 1). Paris: STHDA; (2017). p. 188.

Schubert E, Rousseeuw PJ. Faster k-medoids clustering: improving the PAM, CLARA, and CLARANS algorithms, In:Amato G, Gennaro C, Oria V, Radovanović M, ed. Similarity Search and Applications. Lecture Notes in Computer Science. Cham: Springer; (2019). p. 171–187. 10.1007/978-3-030-32047-8_16 DOI

Kim JI. The sociology of Longevity: Socioecological Factors of Survival Probability, Gender Inequality Index (GII). London: Cambridge Scholars Publishing; (2022). p. 310.

Oksuzyan A, Juel K, Vaupel JW, Christensen K. Men: good health and high mortality. Sex differences in health and aging. Aging Clin Exp Res. (2008) 20:91–102. 10.1007/BF03324754 PubMed DOI PMC

Soofi M, Matin BK, Karyani AK, Rezaei S, Soltani S. Health-care determinants of mortality and recovered cases from COVID-19: do heath systems respond COVID-19 similarly? J Educ Health Promot. (2021) 10:260. 10.4103/jehp.jehp_1509_20 PubMed DOI PMC

Upadhyay AK, Shukla S. Correlation study to identify the factors affecting COVID-19 case fatality rates in India. Diabetes Metab Syndr. (2021) 15:993–9. 10.1016/j.dsx.2021.04.025 PubMed DOI PMC

Balkhi B, Alshayban D, Alotaibi NM. Impact of healthcare expenditures on healthcare outcomes in the Middle East and North Africa (MENA) region: a cross-country comparison, 1995–2015. Front Public Health. (2021) 8:624962. 10.3389/fpubh.2020.624962 PubMed DOI PMC

Farag M, Nandakumar AK, Wallack S, Hodgkin D, Gaumer G, Erbil C. Health expenditures, health outcomes and the role of good governance. Int J Health Care Finance Econ. (2013) 13:33–52. 10.1007/s10754-012-9120-3 PubMed DOI

Ibukun CO. The role of governance in the health expenditure-health outcomes nexus: insights from West Africa. Int J Soc Econ. (2021) 48:557–70. 10.1108/IJSE-06-2020-0404 DOI

Ullah I, Ullah A, Ali S, Poulova P, Akbar A, Haroon Shah M, et al. Public health expenditures and health outcomes in Pakistan: evidence from quantile autoregressive distributed lag model. Risk Manag Healthc Policy. (2021) 14:3893–909. 10.2147/RMHP.S316844 PubMed DOI PMC

Makuta I, O'Hare B. Quality of governance, public spending on health and health status in Sub Saharan Africa: a panel data regression analysis. BMC Public Health. (2015) 15:932. 10.1186/s12889-015-2287-z PubMed DOI PMC

Budhdeo S, Watkins J, Atun R, Williams C, Zeltner T, Maruthappu M. Changes in government spending on healthcare and population mortality in the European Union, 1995–2010: a cross-sectional ecological study. J R Soc Med. (2015) 108:490–8. 10.1177/0141076815600907 PubMed DOI PMC

Wirayuda A, Chan MF. A systematic review of sociodemographic, macroeconomic, and health resources factors on life expectance. Asia Pac J Public Health. (2021) 33:335–56. 10.1177/1010539520983671 PubMed DOI

Kiadaliri A. Avoidable deaths in Sweden, 1997–2018: temporal trend and the contribution to the gender gap in life expectancy. BMC Public Health. (2021) 21:519. 10.1186/s12889-021-10567-5 PubMed DOI PMC

World Bank . Investing in Health: World Development Report. New York: Oxford University Press for the World Bank. (1993). Available online at: https://openknowledge.worldbank.org/handle/10986/5976 (accessed November 18, 2021).

WHO . Health, Economic Growth, and Poverty Reduction. The Report of Working Group 1 of the Commission on Macroeconomics and Health. Geneva: World Health Organization (2002). Available online at: https://apps.who.int/iris/bitstream/handle/10665/42492/9241590092.pdf;jsessionid=19B0494A7B879D7BE2F98CC714DFCFC5?sequence=1 (accessed November 18, 2021).

Gallardo-Albarrán D. Health and economic development since 1900. Econ Hum Biol. (2018) 31:228–37. 10.1016/j.ehb.2018.08.009 PubMed DOI

Fantini MP, Lenzi J, Franchino G, Raineri C, Burgio A, Frova L, et al. Amenable mortality as a performance indicator of Italian health-care services. BMC Health Serv Res. (2012) 12:310. 10.1186/1472-6963-12-310 PubMed DOI PMC

Ariste R, Di Matteo L. Value for money: an evaluation of health spending in Canada. Int J Health Econ Manag. (2017) 17:289–310. 10.1007/s10754-016-9204-6 PubMed DOI